1-20 of 33
Authors: J. Jack Lee
Journal Article
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials
JNCI: Journal of the National Cancer Institute, Volume 116, Issue 6, June 2024, Pages 990–994, https://doi.org/10.1093/jnci/djae028
Published: 09 February 2024
Journal Article
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 3, March 2018, Pages 250–257, https://doi.org/10.1093/jnci/djx186
Published: 26 September 2017
Journal Article
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer
JNCI: Journal of the National Cancer Institute, Volume 109, Issue 8, August 2017, djw341, https://doi.org/10.1093/jnci/djw341
Published: 27 February 2017
Journal Article
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
JNCI: Journal of the National Cancer Institute, Volume 109, Issue 6, June 2017, djw297, https://doi.org/10.1093/jnci/djw297
Published: 10 February 2017
Journal Article
Response
JNCI: Journal of the National Cancer Institute, Volume 108, Issue 3, March 2016, djw001, https://doi.org/10.1093/jnci/djw001
Published: 24 February 2016
Journal Article
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval
JNCI: Journal of the National Cancer Institute, Volume 107, Issue 11, November 2015, djv253, https://doi.org/10.1093/jnci/djv253
Published: 15 September 2015
Journal Article
RE: Meta-analysis of the Relationship Between Dose and Benefit in Phase I Targeted Agent Trials Get access
JNCI: Journal of the National Cancer Institute, Volume 105, Issue 11, 5 June 2013, Page 833, https://doi.org/10.1093/jnci/djt100
Published: 29 April 2013
Journal Article
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome Get access
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 228–239, https://doi.org/10.1093/jnci/djr523
Published: 13 January 2012
Journal Article
Demystify Statistical Significance—Time to Move on From the P Value to Bayesian Analysis Get access
JNCI: Journal of the National Cancer Institute, Volume 103, Issue 1, 5 January 2011, Pages 2–3, https://doi.org/10.1093/jnci/djq493
Published: 03 December 2010
Journal Article
Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 12, 16 June 2010, Pages 859–865, https://doi.org/10.1093/jnci/djq179
Published: 16 June 2010
Journal Article
Response: Re: Dose Escalation Methods in Phase I Cancer Clinical Trials Get access
JNCI: Journal of the National Cancer Institute, Volume 101, Issue 24, 16 December 2009, Pages 1733–1735, https://doi.org/10.1093/jnci/djp401
Published: 16 December 2009
Journal Article
Dose Escalation Methods in Phase I Cancer Clinical Trials
JNCI: Journal of the National Cancer Institute, Volume 101, Issue 10, 20 May 2009, Pages 708–720, https://doi.org/10.1093/jnci/djp079
Published: 20 May 2009
Journal Article
Identification of the Retinoic Acid–Inducible Gprc5a As a New Lung Tumor Suppressor Gene Get access
JNCI: Journal of the National Cancer Institute, Volume 99, Issue 22, 21 November 2007, Pages 1668–1682, https://doi.org/10.1093/jnci/djm208
Published: 21 November 2007
Journal Article
Proliferative Changes in the Bronchial Epithelium of Former Smokers Treated With Retinoids Get access
JNCI: Journal of the National Cancer Institute, Volume 99, Issue 21, 7 November 2007, Pages 1603–1612, https://doi.org/10.1093/jnci/djm205
Published: 07 November 2007
Journal Article
Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients Get access
JNCI: Journal of the National Cancer Institute, Volume 98, Issue 7, 5 April 2006, Pages 441–450, https://doi.org/10.1093/jnci/djj091
Published: 05 April 2006
Journal Article
Treatment of Former Smokers With 9-cis-Retinoic Acid Reverses Loss of Retinoic Acid Receptor-β Expression in the Bronchial Epithelium: Results From a Randomized Placebo-Controlled Trial Get access
JNCI: Journal of the National Cancer Institute, Volume 95, Issue 3, 5 February 2003, Pages 206–214, https://doi.org/10.1093/jnci/95.3.206
Published: 05 February 2003
Journal Article
Cyclin D1 Genotype, Response to Biochemoprevention, and Progression Rate to Upper Aerodigestive Tract Cancer Get access
JNCI: Journal of the National Cancer Institute, Volume 95, Issue 3, 5 February 2003, Pages 198–205, https://doi.org/10.1093/jnci/95.3.198
Published: 05 February 2003
Journal Article
Retinoic Acid Receptor β and Telomerase Catalytic Subunit Expression in Bronchial Epithelium of Heavy Smokers Get access
JNCI: Journal of the National Cancer Institute, Volume 95, Issue 2, 15 January 2003, Pages 165–168, https://doi.org/10.1093/jnci/95.2.165
Published: 15 January 2003
Journal Article
Effects of N-(4-Hydroxyphenyl)retinamide on hTERT Expression in the Bronchial Epithelium of Cigarette Smokers Get access
JNCI: Journal of the National Cancer Institute, Volume 93, Issue 16, 15 August 2001, Pages 1257–1263, https://doi.org/10.1093/jnci/93.16.1257
Published: 15 August 2001
Journal Article
Long-Term Impact of Smoking on Lung Epithelial Proliferation in Current and Former Smokers Get access
JNCI: Journal of the National Cancer Institute, Volume 93, Issue 14, 18 July 2001, Pages 1081–1088, https://doi.org/10.1093/jnci/93.14.1081
Published: 18 July 2001
